Our Approach
ResetBio combines single-cell RNA/TCR sequencing, spectral flow cytometry and targeted antibody discovery to identify patient-relevant disease-driving T cells. The goal is to remove pathogenic clones without broadly flattening immune diversity.
A measured path to targeted T-cell care.
Philosophy
Precision should mean restraint, not blanket suppression.
Protect
Preserve useful immune diversity while focusing attention on the cells most likely to be driving disease.
Measure
Use high-resolution immune profiling to observe clone behavior, track response and refine treatment decisions over time.
Translate
Turn biological signal into practical diagnostics and therapeutic strategies that can move toward clinical care.